1.3(top 50%)
impact factor
2.5K(top 10%)
papers
27.2K(top 10%)
citations
57(top 10%)
h-index
1.4(top 50%)
extended IF
3.0K
all documents
28.5K
doc citations
90(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Extracorporeal Endotoxin Removal For The Treatment of Sepsis:Endotoxin Adsorption Cartridge (Toraymyxin)Therapeutic Apheresis and Dialysis2003703
2Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone DisorderTherapeutic Apheresis and Dialysis2013305
3An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)Therapeutic Apheresis and Dialysis2015275
4Adacolumn, an Adsorptive Carrier Based Granulocyte and MonocyteApheresis Device for the Treatment of Inflammatory and RefractoryDiseases Associated with LeukocytesTherapeutic Apheresis and Dialysis2003234
52008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney DiseaseTherapeutic Apheresis and Dialysis2010211
6Clinical Practice Guideline for the Management of Secondary Hyperparathyroidism in Chronic Dialysis PatientsTherapeutic Apheresis and Dialysis2008164
7Overview of Regular Dialysis Treatment in Japan (as of 31 December 2008)Therapeutic Apheresis and Dialysis2010151
8Long-term Effect of Low-density Lipoprotein Apheresis in Patients with Homozygous Familial HypercholesterolemiaTherapeutic Apheresis and Dialysis2003149
92011 update Japanese Society for Dialysis Therapy Guidelines of Vascular Access Construction and Repair for Chronic HemodialysisTherapeutic Apheresis and Dialysis2015139
10Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis PatientsTherapeutic Apheresis and Dialysis2013133
11Overview of Regular Dialysis Treatment in Japan (as of 31 December 2011)Therapeutic Apheresis and Dialysis2013132
12Sevelamer Hydrochloride and Calcium Bicarbonate Reduce Serum Fibroblast Growth Factor 23 Levels in Dialysis PatientsTherapeutic Apheresis and Dialysis2005131
13Complications of Therapeutic Plasma Exchange: Experience With 4857 TreatmentsTherapeutic Apheresis and Dialysis2005129
14Extracorporeal Photochemotherapy for the Treatment of Graft‐Versus‐Host DiseaseTherapeutic Apheresis and Dialysis2002117
15An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2012)Therapeutic Apheresis and Dialysis2014115
16Inhibition of Intestinal Sodium‐dependent Inorganic Phosphate Transport by Fibroblast Growth Factor 23Therapeutic Apheresis and Dialysis2005114
17Drug-induced Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome: A Concise ReviewTherapeutic Apheresis and Dialysis2004112
18An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)Therapeutic Apheresis and Dialysis2012111
19Improvement of Multiple Organ Functions in Hepatorenal Syndrome During Albumin Dialysis with the Molecular Adsorbent Recirculating SystemTherapeutic Apheresis and Dialysis2001109
20Japanese Society for Dialysis Therapy Guidelines for Management of Cardiovascular Diseases in Patients on Chronic HemodialysisTherapeutic Apheresis and Dialysis2012109
21Studies on the Mechanisms of Leukocyte Adhesion to Cellulose Acetate Beads: An In Vitro Model to Assess the Efficacy of Cellulose Acetate Carrier‐based Granulocyte and Monocyte Adsorptive ApheresisTherapeutic Apheresis and Dialysis2003107
222005 Japanese Society for Dialysis Therapy Guidelines for Vascular Access Construction and Repair for Chronic HemodialysisTherapeutic Apheresis and Dialysis2006104
23Role of Indoxyl Sulfate in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Experimental and Clinical Effects of Oral Sorbent AST‐120Therapeutic Apheresis and Dialysis201199
24Atypical Hemolytic‐Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and TreatmentTherapeutic Apheresis and Dialysis201995
25An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2007)Therapeutic Apheresis and Dialysis200990
26Effects of Serum Calcium, Phosphorous, and Intact Parathyroid Hormone Levels on Survival in Chronic Hemodialysis Patients in JapanTherapeutic Apheresis and Dialysis200888
27Severe Hypertriglyceridemia‐Related Acute PancreatitisTherapeutic Apheresis and Dialysis201388
28Japanese Society for Dialysis Therapy Clinical Guideline for “Maintenance Hemodialysis: Hemodialysis Prescriptions”Therapeutic Apheresis and Dialysis201588
29Role of Plasma Exchange in the Thyroid StormTherapeutic Apheresis and Dialysis201185
30In Vitro Evaluation of High Mobility Group Box 1 Protein Removal with Various Membranes for Continuous HemofiltrationTherapeutic Apheresis and Dialysis201184
31Overview of Regular Dialysis Treatment in Japan (as of 31 December 2009)Therapeutic Apheresis and Dialysis201283
32Standard on Microbiological Management of Fluids for Hemodialysis and Related Therapies by the Japanese Society for Dialysis Therapy 2008Therapeutic Apheresis and Dialysis200981
33Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label StudyTherapeutic Apheresis and Dialysis202081
34The Role of Plasmapheresis in the Treatment of Severe Central Nervous System Neuropsychiatric Systemic Lupus ErythematosusTherapeutic Apheresis and Dialysis200380
35Intermittent Plasmapheresis Prevents Recurrence in Neuromyelitis OpticaTherapeutic Apheresis and Dialysis200978
36Therapeutic Apheresis-State of the Art in the Year 2005Therapeutic Apheresis and Dialysis200576
37Plasmapheresis in Thrombotic Microangiopathy-Associated Syndromes: Review of Outcome Data Derived from Clinical Trials and Open StudiesTherapeutic Apheresis and Dialysis200275
38Prevention of Limb Amputation in Patients with Limbs Ulcers by Autologous Peripheral Blood Mononuclear Cell ImplantationTherapeutic Apheresis and Dialysis200575
39Removal of Humoral Mediators and the Effect on the Survival of Septic Patients by Hemoperfusion With Neutral Microporous Resin ColumnTherapeutic Apheresis and Dialysis201075
40Role of Oxidative Stress and Indoxyl Sulfate in Progression of Cardiovascular Disease in Chronic Kidney DiseaseTherapeutic Apheresis and Dialysis201175
41Low-density Lipoprotein Apheresis: An OverviewTherapeutic Apheresis and Dialysis200373
42AST-120, an Oral Adsorbent, Delays the Initiation of Dialysis in Patients With Chronic Kidney DiseasesTherapeutic Apheresis and Dialysis200772
43Current Topics on Cytokine Removal TechnologiesTherapeutic Apheresis and Dialysis200171
44Management of Intra-abdominal Hypertension in Patients With Severe Acute Pancreatitis With Continuous Hemodiafiltration Using a Polymethyl Methacrylate Membrane HemofilterTherapeutic Apheresis and Dialysis200571
452004 Japanese Society for Dialysis Therapy Guidelines for Renal Anemia in Chronic Hemodialysis Patients*Therapeutic Apheresis and Dialysis200467
46Zinc Deficiency Anemia and Effects of Zinc Therapy in Maintenance Hemodialysis PatientsTherapeutic Apheresis and Dialysis200967
47Plasma Exchange in Patients with Toxic Epidermal NecrolysisTherapeutic Apheresis and Dialysis200266
48Lanthanum Carbonate Effectively Controls Serum Phosphate Without Affecting Serum Calcium Levels in Patients Undergoing HemodialysisTherapeutic Apheresis and Dialysis200866
49Occult Hepatitis B Virus Infection in Hemodialysis Patients With Isolated Hepatitis B Core Antibody: A Multicenter StudyTherapeutic Apheresis and Dialysis201066
50Best Practice for Diabetic Patients on Hemodialysis 2012Therapeutic Apheresis and Dialysis201564